Activation of diacylglycerol and protein kinase C by oxidants and advanced glycation end-products in vascular cells

被引:0
|
作者
Yamauchi, T [1 ]
Sugimoto, N [1 ]
Tanaka, S [1 ]
Takano, S [1 ]
Haji, M [1 ]
Kunisaki, M [1 ]
Umeda, F [1 ]
Nawata, H [1 ]
King, GL [1 ]
机构
[1] Kyushu Univ, Fac Med, Dept Internal Med 3, Fukuoka 812, Japan
关键词
protein kinase C; diacylglycerol; advanced glycation end-products; and H2O2;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Excessive activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway can be important mechanism by which oxidants (H2O2) and advanced glycation end-products (AGE) can induce vascular dysfunction for the development of diabetic vascular complications. When the rat aortic smooth muscle cells (RASMC) were treated with H2O2 and AGE-BSA, in situ PKC activities were significantly increased. We have also found that H2O2 and AGE-BSA increased total DAG levels in RASMC. In RASMC containing labeled arachidonate (Ar) or palmitate (P), H2O2 increased Ar-DAG, while AGE-BSA increased Ar-DAG and P-DAG. We examined tyrosine phosphorylation of phospholipase C gamma (PLC-gamma) and phospholipase D (PLD), a marker of activation. H2O2 showed the increase of tyrosine phosphorylation of PLC-gamma, while AGE-BSA increased both tyrosine phosphorylation of PLC-gamma and PLD. Thus, oxidants and AGE may enhance the DAG-PKC pathway via PLC-gamma or PLD activation, indicating PKC activation by a novel signal transduction pathway.
引用
收藏
页码:341 / 344
页数:4
相关论文
共 50 条
  • [21] Advanced glycation end-products and peritoneal sclerosis
    Nakamura, S
    Niwa, T
    SEMINARS IN NEPHROLOGY, 2004, 24 (05) : 502 - 505
  • [22] Erratum to: Advanced glycation end-products: a review
    R. Singh
    A. Barden
    T. Mori
    L. Beilin
    Diabetologia, 2002, 45 : 293 - 293
  • [23] Methods to assess advanced glycation end-products
    Jaisson, Stephane
    Gillery, Philippe
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2021, 24 (05): : 411 - 415
  • [24] Association of advanced glycation end-products levels with vascular events in postmenopausal women
    Urano, Tomohiko
    Shiraki, Masataka
    Imai, Takumi
    Iinuma, Norio
    Kuroda, Tatsuhiko
    Tanaka, Shiro
    Saito, Mitsuru
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2021, 21 (08) : 651 - 656
  • [25] The role of advanced glycation end-products (AGEs) in the development of vascular diabetic complications
    Barbosa, Junia H. P.
    Oliveira, Suzana L.
    Seara, Luci Tojal E.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2008, 52 (06) : 940 - 950
  • [26] Controlling the receptor for advanced glycation end-products to conquer diabetic vascular complications
    Yamamoto, Yasuhiko
    Yamamoto, Hiroshi
    JOURNAL OF DIABETES INVESTIGATION, 2012, 3 (02): : 107 - 114
  • [27] Serum and Tissue Accumulation of Advanced Glycation End-Products Correlates with Vascular Changes
    Hocine, Aldjia
    Belmokhtar, Karim
    Bauley, Karine
    Jaisson, Stephane
    Gaha, Khaled
    Oubaya, Nadia
    Lesaffre, Francois
    Lavaud, Sylvie
    Halin, Pascale
    Gillery, Philippe
    Rieu, Philippe
    Toure, Fatouma
    PERITONEAL DIALYSIS INTERNATIONAL, 2015, 35 (05): : 592 - 594
  • [28] Expression of receptors for advanced glycation end-products in occlusive vascular and renal disease
    Bierhaus, A
    Ritz, E
    Nawroth, RP
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 : 87 - 90
  • [29] Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells
    Virginia Gangoiti, Maria
    Maria Cortizo, Ana
    Arnol, Veronica
    Ignacio Felice, Juan
    Desmond McCarthy, Antonio
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 600 (1-3) : 140 - 147
  • [30] Effect of advanced glycation end-products (AGEs) on breast cancer cells
    Sharaf, H.
    Matou-Nasri, S.
    Wang, Q.
    Nessar, A.
    DIABETIC MEDICINE, 2013, 30 : 65 - 66